Skip to main content
. 2022 Jul 30;10(8):1843. doi: 10.3390/biomedicines10081843

Figure 9.

Figure 9

Reconstructed proteins and control proteins mediated ADCC against MDA-MB-231 cells. The plots show a dose-dependent increase in the proportion of lysed tumor cells for (A) controls (anti-PD-L1 mAb, CV1-Fc, Fc-CV1) and (B) reconstructed proteins (Pro1, Pro2, and Pro3).